Jayawardhana J, Abraham A and Perri M. Opioids in Georgia Medicaid: Gender and Insurance Disparities in Utilization and Potential Inappropriate Prescribing Practices. Journal of Pharmaceutical Health Services Research, In Press.
Huh J, Bhutada N, Rollins B, and Perri M. Effects of Endorser Type and Testimonials in Direct-to-Consumer Prescriptions Drug Advertising. American Academy of Advertising, Journal of Advertising, October 9, 2017, in press.
Surbhi Shah, MS, Hongye Wei, MS, Jayani Jayawardhana, Ph.D., Matthew Perri, Ph.D., Ewan Cobran, Ph.D., Henry N. Young, Ph.D Cost utility analysis of Methylphenidate and Amphetamine/Dexamphetamine in adults with Attention-deficit hyperactivity disorder. Journal of Pharmaceutical Health Services Research. March 2017.
Wang Y and Perri M. The Impact of Formulary Restrictions on Brand Loyalty and Physicians’ Prescribing Behavior. AMHCR Proceedings, 2017 p65.
Al-Shatnawi S, Perri M, Young HN, Norton M. Substance Use Attitudes, Behaviors, Education and Prevention in Colleges of Pharmacy in the United States. Am J of Pharm Ed 80(9) November 2016.
Extavour R and Perri M. Patient, physician and health-system factors influencing the quality of antidepressant and sedative prescribing for older, community-dwelling adults. Health Services Research, December 2016, DOI: 10.1111/1475-6773.12641
Perri M. Is Direct Pharmaceutical Advertising Right for U.S.? Advances in Health Care Research, Association for Marketing and Health Care Research Proceedings, Mar 2016:112
Bhutada N, Rollins B and Perri M. Impact of animated spokes-characters in print direct-to-consumer prescription drug advertising: An Elaboration Likelihood Model Approach. Journal of Health Communication. 2016 June 17:391-400.
Bhutada N, Rollins B and Perri M. Endorsements in Direct-to-consumer Advertising: Do Endorser Testimonials Work? Advances in Health Care Research, Association for Marketing and Health Care Research Proceedings, Mar 2015, p.105.
Bhutada N, Rollins B and Perri M. Impact of Third-Party Organization Approval Claims in Direct-to-Consumer Advertising. Advances in Health Care Research, Association for Marketing and Health Care Research Proceedings, Mar 2015, p.106.
Rollins B, Ramakrishnan S and Perri M. Direct to Consumer Advertising of Predictive Genetic Tests: A Health Belief Model Based Examination of Consumer Response. Health Marketing Quarterly. 2014; 31:263-278.
Huang M, Huston S, Perri M. Awareness of US Genetic Information Non-discrimination Act of 2008: An on-line Survey. Journal of Pharmaceutical Health Services Research. 2014; 4(4):235-238.
Bhutada, Rollins and Perri. Animation in Print Direct-to-consumer Advertising of Prescription Drugs: Impact on Consumers. Advances in Health Care Research, Association for Marketing and Health Care Research Proceedings, Mar 2013, p.64-70.
Bhutada N, Deshpande A, Perri M. Consumer Evaluation of Brief Summary Formats of Print Direct-to-Consumer Prescription Drug Advertisements. International Journal of Pharmaceutical and Health Care Marketing. 2013; 7:296-312.
Rollins B, Ramakrishnan S and Perri M. An Experimental Examination of Consumer Attitudes, Behavioral Intentions and Information Search Behavior After Viewing A Predictive Genetic Test Direct-to-Consumer Advertisement. International Journal of Pharmaceutical and Health Care Marketing. 2013; 7(3): 285-295.
Sattler L, Perri M and Lee JS. Medication Adherence Measures Derived From Administrative Pharmacy Claims Data in Older Americans: A Systematic Review. Drugs and Aging. 2013;30:383-399.
Bhutada N Rollins B and Perri M. Animation in print direct to consumer advertising of prescription drugs: impact on consumers. Advances in Health Care Research, Association for Marketing and Health Care Research Conference Proceedings. 2013:64-70.
Rollins B, Ramakrishnan S and Perri M. An Experimental Examination of Consumer Attitudes, Behavioral intentions and Information Search Behavior after Viewing a Predictive Genetic Test Direct-to-Consumer Advertisement. Advances in Health Care Research, Association for Marketing and Health Care Research Conference Proceedings. 2013:117-132.
Huang M and Perri M. Consumer Preferences for the Predictive Genetic Tests for Alzheimer’s Disease: A Review Article. Farmeconomica: Health Economics and Therapeutic Pathways 2012; 13(2): 61-67 .
Ramakrishnan, S, Rollins B, and Perri M. Direct-to-Consumer Advertising of Predictive Genetic Tests: Using the Theory of Reasoned Action to Examine Consumer Behavioral Intentions. Journal of Health and Mass Communication. (Published March 2012) 2011; 3(1-4):30-45.
Bhutada N, Deshpande A, Menon A and Perri M. Impact of Celebrity Pitch in Direct-to-Consumer Advertising of Prescription Drugs. Health Marketing Quarterly March 2012;29:35-48.
Rollins B, Ramakrishnan S and Perri M. An Experimental Examination of Consumer Attitudes, Behavioral Intentions and Information Search Behavior after Viewing a Predictive Genetic Test Direct-to-Consumer Advertisement. Association for Marketing and Health Care Research, Advances in Health Care Research. February 2012.
Rollins B, Zinkhan G, King K, and Perri M. Non Branded or Branded DTC Prescription Advertising: Which is more effective? Health Marketing Quarterly, 2011;29(1):86-98. (Article highlighted in Pharmalot March 8, 2011 http://www.pharmalot.com/2011/03/those-non-branded-dtc-ads-seam-to-be-working/)
Rollins B and Perri M. To Brand or Not to Brand? The Question of Current and Future Pharmaceutical Marketing Campaigns. Advances in Health Care Research, Association for Marketing and Health Care Research, Annual Meeting Proceedings. February 2011, 45-46. Available at: http://www.amhcr.org/AMHCR%202011%Proceedings.pdf
Perri M. Information: The Key to Improved Quality in Health Care. Invited Editorial. Population Health Management. January 2011: 1411-12.
Rollins B, Zinkhan G, King K, and Perri M. Behavioral Intentions and Information-Seeking Behavior: A Comparison of Non-branded Versus Branded DTC Prescription Drug Advertisements. Drug Information Journal. November 2010:44(6):673-83.
Walthour A, Seymour L, Tackett RL, Perri M, Assessment of Changes in Utilization of Health-Care Services After Implementation of a Prior Authorization Policy for Atypical Antipsychotic Agents. Annals of Pharmacotherapy, 2010; 44:809-818.
Bhutada N, Cook C and Perri M. Consumers Responses to Coupons in Direct-To-Consumer Advertising of Prescription Drugs, Health Marketing Quarterly, 2010;26:333-346.
Bhutada N and Perri M. Do Coupons in Print Direct-To-Consumer Advertising Influence on Consumers?” Proceedings. Advances in Health Care Research, Association for Marketing and Health Care Research, February 2009, awarded best paper.
Fu AZ, Jiang JZ, Reeves JH, Fincham JE, Liu GG, Perri M. Potentially Inappropriate Medication Use and Healthcare Expenditures in the US Community-Dwelling Elderly, Medical Care 2007; 45:472-476
Perri M, Menon A, Deshpande A, Shinde S, Jiang R, Cooper JW, Cook C, Griffin S, and Lorys R. Adverse Outcomes Associated with Inappropriate Drug Use in Nursing Homes, Annals of Pharmacotherapy 2005;39:405-411.
Cook CL, Wade WE, Martin BC and Perri M. Concordance Among Three Self-Reported measures of Medication Adherence and Pharmacy Refill Records. Journal of the American Pharmaceutical Association 2005;45:2:151-159.
Deshpande AD, Menon AM, Perri M and Zinkhan GM. DTC Advertising and its utility in health care decision-making: A consumer perspective. Journal of Health Communication 2004;9:499-513.
Menon AM, Deshpande AD, Zinkhan GM, and Perri M. A Model Assessing the Effectiveness of DTC Advertising. International Journal of Advertising 2004;23:91-118.
Menon A, Deshpande A, Perri M, and Zinkhan G. Consumers’ Attention to the Brief Summary in Print Direct-to-Consumer Advertisements: Perceived Usefulness in Patient-Physician Discussions. Journal of Public Policy and Marketing 2003;22:181-191.
Deshpande AD, Menon AM, Perri M, and Zinkhan GM. The Utility of DTC Advertising for Health Care Decision Making: A Consumer Perspective. Advances in Health Care Research. (Hogan B, Treise B , and Hoverstad R, eds.) Chicago: 2003; American Marketing Association.
Menon AM, Deshpande AD, Perri M, and Zinkhan GM, Trust in Prescription Drug Information: The Internet and its Effect on Information Search Behavior. Health Marketing Quarterly 2003;20:17-35.
Shinde S, Knut A, Hagtvet, Slaughter E, and Perri M, Modeling the Mediation of Consumer Involvement between DTC Ads and Consumer Attitudes. Business and Health Administration Proceedings, DP Paul III and RS Curtis (Eds) 2002:261-268.
Shinde SB, Zinkhan GM, Slaughter E, and Perri M. Factors Influencing Clarity of Direct-to-Consumer Advertisements: A Regression Analysis. Advances in Health Care Research. JS Hair, JM Weber and R Hoverstad (Eds.) 2001;47-56.
The Past, Present and Future of Direct to Consumer Advertising in the Pharmaceutical Industry. Clinical Therapeutics 1999;21:1798-1811.
Poirier S, Jackson R, Perri M and Nichols GN, Noncompliance as a Disease: An Algorithm for Treatment. America’s Pharmacist 1999:Program No. 207-000-98-088-H04
Martin BC, Perri M and Kotzan JA. Health care triage alternatives and the influence of health insurance, education and race. Patient Counseling and Education 1996;28:287-296.
Perri M, Martin BC and Pritchard L, Improving Medication Compliance: A Practical Intervention. Journal of Pharmacy Technology 1995;11:167-172.
Perri M and Wolfgang AP. Consumers’ Cognitive and Behavioral Responses to a Health Related Educational Advertising Campaign. Journal of Pharm Marketing and Management 1992;6:75-88.
Perri M. An Experimental Intervention: Stimulating Requests for Generic Medications. Journal of Pharmaceutical Marketing and Management 1989;3:21-36.
Perri M. and Dickson WM. Consumer Reaction to a Direct To Consumer Prescription Drug Advertising Campaign. Journal of Health Care Marketing 1988;8:66 69.
Perri M. and Dickson WM. Consumer and Physician Attitudes Toward Direct to Consumer Advertising. Journal of Pharmaceutical Marketing and Management 1987;2:3 25.
Perri M and Nelson AA. An Exploratory Analysis of Consumer Recognition of Direct to Consumer Advertising of Prescription Medications. Journal of Health Care Marketing 1987;7:9 17.
GA Department of Community Health (Medicaid), Neuopsychiatric EEG-Based ADHD Assessment Aid (NEBA) Monitoring Study, 2017-2019; $50,000, Principle Investigator.
UGA SBIRT Interprofessional Training Program, Grant No: 1H79T1026457-01, 2016-2019; $851,016. Department of Health and Human Services, Co-Investigator
Opiod Prescribing in Medicaid: Healthcare Utilizaiont and Deaths from Overdose. Grant No: 1R01DA039930-01A1, 2016-2019; $675,000. National Institutes of Health (NIDA), Principle Investigator (Co PI, J. Jayawardhana).
Prescriber Education, US Attorney General Consumber and Prescriber Grant Program. 2006-2008; $396,000. Principle Investigator (Co PI, R. Tackett).
Perri M, Walthour A. American Foundation for Pharmaceutical Education, $5,000, 2007-08.
Perri M, Walthour A. American Foundation for Pharmaceutical Education, $6,000, 2007-08.
Perri M, Rollins B. American Foundation for Pharmaceutical Education, $6000, 2007-08.
Perri M, Rollins B. American Foundation for Pharmaceutical Education, $6,000, 2006.
Perri M. Roger Green and Associates Graduate Student Training in Marketing Research, 2000-2006; $181,500.
Griffin S, Aull L, Herist K, and Perri M, Insulin Resistance Clinical Trial; Co-investigator, 2006-2008, $42,486.
Perri M and Deshpande A. Drug Information Association, Communicating Benefit and Risk Information in Direct-to-Consumer Advertising, 2004-05, $23,000.
Perri M and Shindes SB. Antecedents of Drug Requesting Behavior, Sankyo Pharma, 2003, $10,000.
Perri M and Johnson T. Long Term Care Intervention Team: Implications for Outcomes and Public Policy, Department of Community Health, State of GA, 2002, $115,000.
Perri M and Cook C. Patient Satisfaction with Managed Care Pharmacy Services, UpJohn, 1997, $5,000.
Perri M and Kamath AR. R&D Productivity in the Pharmaceutical Industry, Elan Corporation, 1996, $3,097.
Neel A, Pittman J, Marasco R, Pritchard L, Perri M., Reese L., Morton M., “A Tacrine HCL Outcomes Research Project in a Long Term Care Facility, Warner Lambert Park- Davis, 1995, $315,000 (consultant only).
Pritchard L and Perri M. “Examining the Quality of Service of Two Different Pharmacy Designs: The Patients Perspective”, Wal-Mart Inc., 1995, $11,598.
Perri M and Martin B. “Improving Medication Compliance: A Practical Intervention”, The West Company, 1993, $26,600.
Perri M and Pritchard FL. “OBRA 90: A BluePrint for Quality Pharmaceutical Care”, Glaxo, Inc., 1993, $15,000.
Perri M, Kotzan JA, Francisco G and Pritchard F. “The Impact of OBRA 90 on the Practice of Pharmacy in the State of Georgia”, Georgia Department of Medical Assistance, one year, 1992, $33,265.
Francisco G and Perri M. “Developing a Curriculum to Train Pharmacists to Provide Pharmaceutical Care in the Community Chain Pharmacy Setting”, American Association of Colleges of Pharmacy, 1992, $32,412.
Perri M and Wolfgang AP. “Hospital Pharmacy Salary Survey 1991”, $1,000; “Hospital Pharmacy Salary Survey 1990”, $1,000; “Hospital Pharmacy Salary Survey 1989”, $750; “Hospital Pharmacy Salary Survey, 1988”, $750; “Hospital Pharmacy Salary Survey, 1987”, Georgia Society of Hospital Pharmacists, $750. (Annual Survey)
Park, D.C. and Morrell, R., “Intervention Strategies to Improve Drug Compliance in Community Dwelling Older Adults”, AARP Andrus Foundation, M. Perri (project consultant) July 1989, $76,842.
Perri M and Kotzan JA. “An Analysis of Consulting Pharmacist Effectiveness for Medicaid Patients in Nursing Homes”, Georgia Department of Medical Assistance, July 1989, $5,775.
Kotzan JA and Perri M. “An Analysis for Potential Savings Earned from a Starter Dose Program for Anti-arthritic Drug Products for Medicaid Recipients”, State of Georgia, Department of Medical Assistance, Atlanta, GA, 1989 $3,613.
Perri M, Wolfgang AP, Park D and Carroll NV. “Older Adults and Generic Medications: Intervention Strategies to Enhance Usage”, The American Association of Retired Persons (AARP) Andrus Foundation, April 1988, $65,769.
Perri M. “Health Care Information Through Public Advertising”, Faculty Research Grants, Office of Vice President for Research, July 1986, $2,500.
Perri M. “Development of a Case Study Teaching a Method in Pharmacy Management”, The Lilly Foundation, through Office of Instructional Development, May 1986, $3,000.
Perri M. “An Interactive Computer Learning Center”, Instructional Services Grants, University of Georgia Office of Instructional Development, March 1986, $1,000.
Kotzan JA, Perri M, Carroll NV, and Wolfgang AP. “Pharmacy Management Studies”, Eckerd Foundation, 1985, $40,000.
Perri M, Cooper JW, Ozburn WE, (1993-1997) “Alzheimers Disease Counseling Guidebook”, Post-graduate continuing education contract, through Warner Lambert Parke Davis, $15,740.
Perri M and Ozburn W, (1994) Pharmacist Training Program, Post-graduate continuing education contract, through Promotions Unlimited, $3,000.
Perri M, Pritchard FL, Ozburn WE and Gammil C. (1993) “OBRA 90 a Blueprint for Quality Pharmaceutical Care”, Post-graduate continuing education contract, through Glaxo Inc, $10,580.